ELUTIA INC. — Director's Dealing 2020

Dec 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AYZO)
CIK: 0001708527
Period of Report: 2020-12-09

Reporting Person: Mills C Randal (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-09	STOCK OPTION (RIGHT TO BUY)	$17.00	A	14307	Acquired	2030-12-08	CLASS A COMMON STOCK (14307)	Direct

Footnotes

F1: This option vests and becomes exercisable in three equal installments on each of October 8, 2021, 2022 and 2023.